Search

everythinglearnresearchcommunity

for

Search:↓

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Secukinumab can cause hair loss, which may improve after stopping the medication.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Dupilumab for eczema may cause hair loss.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Immune cells affect hair growth and could lead to new hair loss treatments.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

TNF-alpha inhibitors can cause various immune-related skin issues.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.